167 related articles for article (PubMed ID: 34455229)
21. Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany.
Vetter L; Keller M; Bruckner T; Golatta M; Eismann S; Evers C; Dikow N; Sohn C; Heil J; Schott S
Breast Cancer Res Treat; 2016 Apr; 156(2):289-99. PubMed ID: 26960712
[TBL] [Abstract][Full Text] [Related]
22. Nonverbal communication and conversational contribution in breast cancer genetic counseling: are counselors' nonverbal communication and conversational contribution associated with counselees' satisfaction, needs fulfillment and state anxiety in breast cancer genetic counseling?
Dijkstra H; Albada A; Klöckner Cronauer C; Ausems MG; van Dulmen S
Patient Educ Couns; 2013 Nov; 93(2):216-23. PubMed ID: 23786807
[TBL] [Abstract][Full Text] [Related]
23. Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.
Brédart A; Kop JL; Dick J; Cano A; De Pauw A; Anota A; Brunet J; Devilee P; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S
BMJ Open; 2019 Sep; 9(9):e029926. PubMed ID: 31551380
[TBL] [Abstract][Full Text] [Related]
24. Follow-up effects of a tailored pre-counseling website with question prompt in breast cancer genetic counseling.
Albada A; van Dulmen S; Spreeuwenberg P; Ausems MG
Patient Educ Couns; 2015 Jan; 98(1):69-76. PubMed ID: 25455796
[TBL] [Abstract][Full Text] [Related]
25. Risk communication in completed series of breast cancer genetic counseling visits.
Pieterse AH; van Dulmen S; van Dijk S; Bensing JM; Ausems MG
Genet Med; 2006 Nov; 8(11):688-96. PubMed ID: 17108760
[TBL] [Abstract][Full Text] [Related]
26. A pre-visit website with question prompt sheet for counselees facilitates communication in the first consultation for breast cancer genetic counseling: findings from a randomized controlled trial.
Albada A; van Dulmen S; Ausems MG; Bensing JM
Genet Med; 2012 May; 14(5):535-42. PubMed ID: 22241101
[TBL] [Abstract][Full Text] [Related]
27. Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.
Padmanabhan H; Hassan NT; Wong SW; Lee YQ; Lim J; Hasan SN; Yip CH; Teo SH; Thong MK; Mohd Taib NA; Yoon SY
PLoS One; 2022; 17(2):e0263675. PubMed ID: 35167615
[TBL] [Abstract][Full Text] [Related]
28. Medical knowledge and information needs among women with pathogenic variants in moderate-risk genes for hereditary breast cancer attending genetic counseling at an academic hospital in Germany-A qualitative approach.
Stracke C; Lemmen C; Rhiem K; Schmutzler R; Kautz-Freimuth S; Stock S
J Genet Couns; 2022 Jun; 31(3):698-712. PubMed ID: 34837291
[TBL] [Abstract][Full Text] [Related]
29. The influence of dispositional optimism on post-visit anxiety and risk perception accuracy among breast cancer genetic counselees.
Wiering BM; Albada A; Bensing JM; Ausems MG; van Dulmen AM
Psychooncology; 2013 Nov; 22(11):2419-27. PubMed ID: 23630180
[TBL] [Abstract][Full Text] [Related]
30. Familial breast cancer: Genetic counseling over time, including patients´ expectations and initiators considering the Angelina Jolie effect.
Evers C; Fischer C; Dikow N; Schott S
PLoS One; 2017; 12(5):e0177893. PubMed ID: 28542378
[TBL] [Abstract][Full Text] [Related]
31. Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.
Kraus C; Hoyer J; Vasileiou G; Wunderle M; Lux MP; Fasching PA; Krumbiegel M; Uebe S; Reuter M; Beckmann MW; Reis A
Int J Cancer; 2017 Jan; 140(1):95-102. PubMed ID: 27616075
[TBL] [Abstract][Full Text] [Related]
32. Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis.
Sandoval RL; Leite ACR; Barbalho DM; Assad DX; Barroso R; Polidorio N; Dos Anjos CH; de Miranda AD; Ferreira ACSM; Fernandes GDS; Achatz MI
PLoS One; 2021; 16(2):e0247363. PubMed ID: 33606809
[TBL] [Abstract][Full Text] [Related]
33. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P; Janoutova J; Hermanova B
Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
[TBL] [Abstract][Full Text] [Related]
34. Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations.
Sato K; Koyasu M; Nomura S; Sato Y; Kita M; Ashihara Y; Adachi Y; Ohno S; Iwase T; Kitagawa D; Nakashima E; Yoshida R; Miki Y; Arai M
Cancer Sci; 2017 Nov; 108(11):2287-2294. PubMed ID: 28796317
[TBL] [Abstract][Full Text] [Related]
35. Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers.
Cragun D; Weidner A; Tezak A; Clouse K; Pal T
Breast Cancer Res Treat; 2020 Jul; 182(2):421-428. PubMed ID: 32445176
[TBL] [Abstract][Full Text] [Related]
36. Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina.
Cerretini R; Mercado G; Morganstein J; Schiaffi J; Reynoso M; Montoya D; Valdéz R; Narod SA; Akbari MR
Breast Cancer Res Treat; 2019 Dec; 178(3):629-636. PubMed ID: 31446535
[TBL] [Abstract][Full Text] [Related]
37. Contribution of large genomic rearrangements in
Li N; Zethoven M; McInerny S; Healey E; DeSilva D; Devereux L; Scott RJ; James PA; Campbell IG
J Med Genet; 2023 Feb; 60(2):112-118. PubMed ID: 35396271
[TBL] [Abstract][Full Text] [Related]
38. Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer.
Brédart A; Kop JL; Depauw A; Caron O; Sultan S; Leblond D; Fajac A; Buecher B; Gauthier-Villars M; Noguès C; Flahault C; Stoppa-Lyonnet D; Dolbeault S
Br J Cancer; 2013 Mar; 108(5):1012-20. PubMed ID: 23462725
[TBL] [Abstract][Full Text] [Related]
39. Communication in cancer genetic counselling: does it reflect counselees' previsit needs and preferences?
Pieterse AH; van Dulmen AM; Ausems MG; Beemer FA; Bensing JM
Br J Cancer; 2005 May; 92(9):1671-8. PubMed ID: 15841073
[TBL] [Abstract][Full Text] [Related]
40. Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients.
Wu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xu Y; Xie Y
Breast Cancer Res Treat; 2020 Feb; 179(3):605-614. PubMed ID: 31768816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
